New data showed that prior malignancy may influence survival outcomes in patients with metastatic colorectal cancer, ...
Dr. Marwan G. Fakih explains that KRAS mutations, found in 45% of patients with colorectal cancer, include the rare KRAS G12C mutation, leading to Lumakras approval.
FOX 4 Dallas-Fort Worth on MSN6d
Mansfield man undergoes double lung transplant with groundbreaking 'lungs in a fridge' technologyThe new “lungs in a fridge” tech can keep the lungs intact for up to 18 hours, compared to about four hours when kept on it.
6d
The medical world is celebrating two innovative technologies Northwestern Medicine is using to help give patients a new ...
The methylation of plasma cell-free DNA (cfDNA) has emerged as a valuable diagnostic and prognostic biomarker in various cancers including colorectal cancer (CRC). Currently, there are no biomarkers ...
Pfizer only picked up an accelerated approval from the FDA for its Braftovi-based combination regimen for colorectal cancer ...
It has since been approved as a second-line colorectal cancer therapy and for treating advanced cases of non-small cell lung cancer ... approval of Braftovi in metastatic colorectal cancer.
The combination of Opdivo and Yervoy is supported by updated results as a standard of care for MSI-H or dMMR metastatic ...
The Phase III trial builds on findings from prior findings that indicated Anktiva can restore T-cell function and improve ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback